United Health Products, Inc. (Form: NT 10-Q, Received: 08/16/2011 14:50:52)












FORM 12b-25

Commission File Number











CUSIP Number




 34416A 203



(Check One):

o  Form 10-K

 Form 20-F

o  Form 11-K

x  Form 10-Q

o  Form N-SAR








For Period Ended: August 31, 2014

o  Transition Report on Form 10-K

o  Transition Report on Form 20-F

o  Transition Report on Form 11-K

o  Transition Report on Form 10-Q

o  Transition Report on Form N-SAR


For the Transition Period Ended:



Read Attached Instruction Sheet Before Preparing Form.  Please Print or Type.

Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.



If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:   N/A

Part I - Registrant Information


Focus Gold Corporation.




Full Name of Registrant:












Former Name if Applicable:  




1365 N. Courtenay Parkway, Suite A








Address of Principal Executive Office (Street and Number)








Merritt Island, FL 32953




(City, State and Zip Code)








Part II - Rules 12b-25(b) and (c)


If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)




The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense.




The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and




The accountant's statement or other exhibit required by Rule 12(b)-25(c) has been attached if applicable.

PART III - Narrative


State below in reasonable detail the reasons why Form 10-K, 20-F, 11-K, 10-Q, N-SAR, or the transition report or portion thereof could not be filed within the prescribed period.


The process of compiling and disseminating the information required to be included in the Form 10Q for the quarter ended August 31, 2014 as well as the completion of the required review of the Companys financial information, could not be completed without incurring undue hardship and expense, due to the Companys inability to obtain financial and other records from management and its advisors, which has required the Company to reconstruct a portion of the records from other sources.  The registrant will file the quarterly report on or before October 20, 2014.


Part IV - Other Information

(1)  Name and telephone number of person to contact in regard to this notification:


John Burke







 (Area Code)


(Telephone No.)







(2)  Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the Registrant was required to file such report(s) been filed? If the answer is no, identify report(s).

x  Yes    o No

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

o  Yes    x No

If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. 


Focus Gold Corporation.

(Name of Registrant as specified in charter)

has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.



October 15, 2014



 /s/ Michael Choo





Michael Choo





Chief Executive Officer


INSTRUCTION :  The form may be signed by an executive officer or by any other duly authorized representative.  The name and title of the person signing the form shall be typed or printed beneath the signature.  If the statement is signed on behalf of the Registrant by an authorized representative (other than an executive officer), evidence of the representative's authority to sign on behalf of the Registrant shall be filed with the form.